Detalhe da pesquisa
1.
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
N Engl J Med
; 386(24): 2261-2272, 2022 06 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35657320
2.
Availability and accessibility of services to address financial toxicity described by Australian lung cancer patients and healthcare professionals.
Support Care Cancer
; 31(9): 554, 2023 Sep 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37659009
3.
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer.
Intern Med J
; 53(9): 1610-1617, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35668542
4.
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Int J Cancer
; 148(4): 1014-1026, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32984952
5.
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
PLoS Med
; 18(5): e1003620, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33939694
6.
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer.
Acta Oncol
; 60(9): 1106-1113, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34184594
7.
Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer.
Intern Med J
; 51(8): 1262-1268, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32896960
8.
Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia.
Intern Med J
; 50(2): 165-172, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30887616
9.
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
Gut
; 68(4): 663-671, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29420226
10.
The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations.
Int J Cancer
; 145(2): 540-547, 2019 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30628066
11.
Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer.
Intern Med J
; 48(12): 1541-1542, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30518000
12.
Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer.
JNCI Cancer Spectr
; 6(1)2022 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35699496
13.
Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.
Asia Pac J Clin Oncol
; 18(5): e363-e368, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35073441
14.
Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.
Int J Cancer
; 128(9): 2075-84, 2011 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20635392
15.
Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.
J Vasc Interv Radiol
; 22(6): 780-6, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21515072
16.
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.
Pharmacoeconomics
; 39(8): 953-964, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34089503
17.
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.
Clin Colorectal Cancer
; 20(4): e233-e239, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34289941
18.
Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status.
Clin Colorectal Cancer
; 20(1): e21-e34, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32919889
19.
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer.
Curr Probl Cancer
; 45(1): 100637, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32826083
20.
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data.
Pharmacoeconomics
; 38(11): 1263-1275, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32803720